DELIVERY OF A DRUG SUSCEPTIBILITY GENE INTO HUMAN-LYMPHOCYTES FOR IN-VIVO ELIMINATION OF ALLOREACTIVE T-CELLS AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION

被引：0
|
作者：
VOGELS, R
HOOGERBRUGGE, PM
BRAAKMAN, E
HAGENBEEK, A
VALERIO, D
机构：
[1] LEIDEN UNIV,DEPT MED BIOCHEM,2300 RA LEIDEN,NETHERLANDS
[2] LEIDEN UNIV,DEPT PEDIAT,2300 RA LEIDEN,NETHERLANDS
[3] ERASMUS UNIV ROTTERDAM,DEPT EXPTL HEMATOL,3000 DR ROTTERDAM,NETHERLANDS
[4] INTROGENE,RIJSWIJK,NETHERLANDS
来源：
JOURNAL OF CELLULAR BIOCHEMISTRY | 1995年
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：428 / 428
页数：1
相关论文
共 50 条
  • [31] THE ROLE OF PURIFIED CD8(+) T-CELLS IN GRAFT-VERSUS-LEUKEMIA ACTIVITY AND ENGRAFTMENT AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
    PALATHUMPAT, V
    DEJBAKHSHJONES, S
    STROBER, S
    TRANSPLANTATION, 1995, 60 (04) : 355 - 361
  • [32] HUMAN BONE-MARROW CD3+CD4-CD8- T-CELLS - IDENTIFICATION AND SEPARATION FOR USE IN BONE-MARROW TRANSPLANTATION (BMT)
    HINKLE, AS
    TAYLOR, BJ
    QUINONES, RR
    PEDIATRIC RESEARCH, 1994, 35 (04) : A162 - A162
  • [33] The contribution of cytotoxic and noncytotoxic function by donor T-cells that support engraftment after allogeneic bone marrow transplantation
    Jiang, Z
    Adams, GB
    Hanash, AM
    Scadden, DT
    Levy, RB
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2002, 8 (11) : 588 - 596
  • [34] ELIMINATION OF T-CELLS FROM ALLOGENEIC BONE-MARROW GRAFTS BY INVITRO INCUBATION WITH THE CYTOLYTIC MONOCLONAL-ANTIBODY CAMPATH-1
    WIESNETH, M
    BUNJES, D
    SCHMEISER, T
    FRICKHOFEN, N
    ARNOLD, R
    HEIT, W
    BLUT, 1984, 49 (03): : 293 - 293
  • [35] DEPLETION OF T-CELLS FROM MISMATCHED ALLOGENEIC BONE-MARROW - RESULTS OF TRANSPLANTATION IN 23 PATIENTS WITH MALIGNANCY OR APLASTIC-ANEMIA
    TRIGG, ME
    BOZDECH, MJ
    SONDEL, PM
    BILLING, R
    FINLAY, JL
    PETERSON, AD
    STUIBER, M
    HONG, R
    EXPERIMENTAL HEMATOLOGY, 1984, 12 (06) : 412 - 412
  • [36] ELIMINATION OF MALIGNANT CLONOGENIC T-CELLS FROM HUMAN BONE-MARROW USING CHEMOIMMUNOSEPARATION WITH 2'-DEOXYCOFORMYCIN, DEOXYADENOSINE AND AN IMMUNOTOXIN
    MONTGOMERY, RB
    KURTZBERG, J
    RHINEHARDTCLARK, A
    HALEEN, A
    RAMAKRISHNAN, S
    OLSEN, GA
    PETERS, WP
    SMITH, CA
    HAYNES, BF
    HOUSTON, LL
    BAST, RC
    BONE MARROW TRANSPLANTATION, 1990, 5 (06) : 395 - 402
  • [37] REPLICATION OF THE HUMAN IMMUNODEFICIENCY VIRUS-1 AND IMPAIRED DIFFERENTIATION OF T-CELLS AFTER INVITRO INFECTION OF BONE-MARROW IMMATURE T-CELLS
    LUNARDIISKANDAR, Y
    NUGEYRE, MT
    GEORGOULIAS, V
    BARRESINOUSSI, F
    JASMIN, C
    CHERMANN, JC
    JOURNAL OF CLINICAL INVESTIGATION, 1989, 83 (02): : 610 - 615
  • [38] PURGING METHODS IN AUTOLOGOUS (REMOVAL OF RESIDUAL MALIGNANT-CELLS) OR ALLOGENEIC (REMOVAL OF T-CELLS) BONE-MARROW TRANSPLANTATION - PILOT-STUDIES
    HERVE, P
    FLESCH, M
    NOUVELLE REVUE FRANCAISE D HEMATOLOGIE, 1986, 28 (02): : 97 - 105
  • [39] INVIVO DETECTION OF HOST ORIGIN ALLOREACTIVE T-CELLS AFTER HLA-IDENTICAL (ID) ALLOGENIC BONE-MARROW GRAFT-REJECTION
    IRLE, C
    CHAPUIS, B
    JEANNET, M
    SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1985, : 10 - 10
  • [40] ANALYSIS OF DIFFERENT PROTEIN-KINASE C-DEPENDENT EVENTS IN T-CELLS FROM ALLOGENEIC BONE-MARROW TRANSPLANTATION RECIPIENTS
    BALBOA, MA
    IZQUIERDO, M
    SANCHEZMADRID, F
    FERNANDEZRANADA, JM
    LOPEZBOTET, M
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1992, 87 (03): : 478 - 484
12345